Myeloid Leukemia — Trials

Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,530 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 862
Recruiting: 498
Ph III recruiting: 47
Growth YoY: +2.9%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (619)

clinicaltrialsPublishedShowing 201–250 of 1,516 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07651176	Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy	enrolling by invitation	Phase 2 / Phase 3	267	First Affiliated Hospital of Zhejiang UniversityOTHER	1	Jun 16, 2026	clinicaltrials
NCT04047641	Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome	recruiting	Phase 1 / Phase 2	80	M.D. Anderson Cancer CenterOTHER